drugset / Trial / NCT04504448
A Study of HNC664 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this First-in-Human study is to evaluate the safety , tolerability，PK and PD after single ascending of HNC664 given to healthy subjects, compared to placebo. Also, food effect will be evaluated.
Timeline
- Start
- 2020-08-11
- Primary completion
- 2021-07-13
- Completion
- 2021-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HNC664 | Unknown | 40 mg | Oral |
| Subject | HNC664 | Unknown | 500 mg | Oral |
Indications
No indication recorded.